AP
BSX icon

Adero Partners’s Boston Scientific BSX Stock Holding History

Adero Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$389K Buy
3,859
+122
+3% +$12.3K 0.03% 147
2024
Q4 		$334K Buy
3,737
+120
+3% +$10.6K 0.02% 160
2024
Q3 		$303K Buy
3,617
+127
+4% +$10K 0.02% 170
2024
Q2 		$269K Buy
+3,490
New +$255K 0.02% 169

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Adero Partners's BSX Position: Q1 2025 in Review

Adero Partners increased its Boston Scientific (BSX) stake by 3.3% in Q1 2025, buying an estimated $12.3K and bringing the position to 3,859 shares worth $389K. The position accounts for 0.03% of the portfolio, ranked #147.

Adero Partners first reported a position in BSX in Q2 2024 and has held it in 4 quarters since. 1,643 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Adero Partners held 3,859 shares of Boston Scientific worth $389K as of Q1 2025.
  • Adero Partners bought 122 Boston Scientific shares in Q1 2025, an estimated $12.3K.
  • Boston Scientific made up 0.03% of Adero Partners's portfolio in Q1 2025, its #147 holding.
  • Adero Partners first reported a position in Boston Scientific in Q2 2024 and has held it in 4 quarters since.
  • 1,643 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Adero Partners's 13F filing for Q1 2025, filed 17 Apr 2025.